Journal
RECOMBINANT GLYCOPROTEIN PRODUCTION: METHODS AND PROTOCOLS
Volume 1674, Issue -, Pages 95-107Publisher
HUMANA PRESS INC
DOI: 10.1007/978-1-4939-7312-5_8
Keywords
Cell-free protein synthesis; Protein expression; Protein biologics; Erythropoietin; Protein purification
Ask authors/readers for more resources
Protein biologics have emerged as a safe and effective group of drug products that can be used in a variety of medical disorders and clinical settings, including treatment of orphan diseases, personalized medicine, and point-of-care applications. However, the full potential of protein biologics for such applications will not be realized until there are methods available for rapid and cost-effective production of small scale products for individual needs. Here, we describe a modular and scalable method for rapid and adaptable production of protein-based medical products at small doses. The method includes cell-free synthesis of the protein target in a reactor module followed by a fluidic process for protein purification. As a proof of concept, we describe the application of this method for expression and purification of a bioactive pharmaceutically relevant protein biologic, recombinant human erythropoietin, at a single dose within 24 h. This method can be applied toward the development of automated platforms for rapid and adaptive production of protein biologics at the point of care in response to specific medical needs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available